News headlines about Markel (NYSE:MKL) have been trending somewhat positive on Sunday, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Markel earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave news stories about the insurance provider an impact score of 45.8521213880709 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Several equities research analysts recently weighed in on the company. Zacks Investment Research upgraded Markel from a “hold” rating to a “buy” rating and set a $1,253.00 target price for the company in a report on Friday. SunTrust Banks restated a “hold” rating and set a $1,100.00 target price on shares of Markel in a report on Friday, October 27th. Boenning Scattergood restated a “buy” rating on shares of Markel in a report on Thursday, October 26th. Finally, Royal Bank of Canada restated a “hold” rating and set a $1,050.00 target price on shares of Markel in a report on Tuesday, October 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $1,113.25.
Markel (NYSE:MKL) traded down $1.04 during midday trading on Friday, reaching $1,117.33. The company’s stock had a trading volume of 27,400 shares, compared to its average volume of 37,928. Markel has a 1-year low of $887.40 and a 1-year high of $1,157.30. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 0.28. The stock has a market cap of $15,520.00, a PE ratio of 248.85 and a beta of 1.04.
In other Markel news, EVP Anne G. Waleski sold 838 shares of the stock in a transaction that occurred on Friday, December 8th. The stock was sold at an average price of $1,102.48, for a total value of $923,878.24. Following the completion of the sale, the executive vice president now owns 4,150 shares in the company, valued at approximately $4,575,292. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Lemuel E. Lewis acquired 1,000 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was acquired at an average price of $1,080.96 per share, with a total value of $1,080,960.00. Following the acquisition, the director now owns 5,294 shares in the company, valued at approximately $5,722,602.24. The disclosure for this purchase can be found here. In the last quarter, insiders sold 2,507 shares of company stock valued at $2,752,492. Company insiders own 2.53% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This article was reported by Equities Focus and is owned by of Equities Focus. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.equitiesfocus.com/2018/01/07/markel-mkl-receiving-somewhat-favorable-media-coverage-report-shows.html.
Markel Company Profile
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.